{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:37:03Z","timestamp":1789425423535,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000555","name":"British Microcirculation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006399","name":"Spectrum Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jtho.2019.05.037","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T21:13:53Z","timestamp":1560201233000},"page":"2053-2061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Defining Synchronous Oligometastatic Non\u2013Small Cell Lung Cancer: A Systematic Review"],"prefix":"10.1016","volume":"14","author":[{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Giaj-Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Durieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktiar","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizza E.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.jtho.2019.05.037_bib1","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib3","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.21037\/jtd.2017.06.133","article-title":"Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer","volume":"9","author":"Ricardi","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2019.05.037_bib4","unstructured":"National Comprehensive Cancer Network. Non-small cell lung cancer (version 3.2018). Accessed December 16,\u00a02018."},{"key":"10.1016\/j.jtho.2019.05.037_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib6","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib7","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1016\/j.jtho.2018.08.529","article-title":"MA25.01 EORTC Lung Cancer Group survey to define synchronous oligometastatic disease in NSCLC","volume":"13","author":"Levy","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib8","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1016\/j.jtho.2018.08.530","article-title":"MA25.02 Searching for a definition of synchronous oligometastatic (sOM)-NSCLC: a consensus from thoracic oncology experts","volume":"13","author":"Dingemans","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib9","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1016\/j.jtho.2018.08.531","article-title":"MA25.03 Defining oligometastatic non-small cell lung cancer (NSCLC): an evolving multidisciplinary expert opinion","volume":"13","author":"Hendriks","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib11","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.athoracsur.2016.04.086","article-title":"Outcomes of a highly selective surgical approach to oligometastatic lung cancer","volume":"102","author":"Johnson","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2019.05.037_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2006.09.006","article-title":"Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC)","volume":"81","author":"Khan","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib13","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ijrobp.2012.02.054","article-title":"Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis","volume":"84","author":"Lopez Guerra","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2019.05.037_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1159\/000365634","article-title":"Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers?","volume":"23","author":"Nieder","year":"2014","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.jtho.2019.05.037_bib15","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2019.05.037_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12262-012-0771-6","article-title":"Surgical treatment of extrapulmonary oligometastatic non-small cell lung cancer","volume":"77","author":"Pl\u00f6nes","year":"2015","journal-title":"Indian J Surg"},{"key":"10.1016\/j.jtho.2019.05.037_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/1759-7714.12386","article-title":"Clinical outcome of node-negative oligometastatic non-small cell lung cancer","volume":"7","author":"Sakai","year":"2016","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2019.05.037_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ijrobp.2014.07.012","article-title":"Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy","volume":"90","author":"Sheu","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2019.05.037_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1186\/s12885-016-2952-3","article-title":"Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies","volume":"16","author":"Su","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtho.2019.05.037_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijrobp.2015.08.012","article-title":"Three-dimensional radiation therapy to the primary tumor with concurrent chemotherapy in patients with stage IV non-small cell lung cancer: results of a multicenter phase 2 study from PPRA-RTOG, China","volume":"93","author":"Su","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2019.05.037_bib21","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.prro.2014.11.006","article-title":"Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: a hypothesis-generating study","volume":"5","author":"Xanthopoulos","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jjco\/hyq044","article-title":"Clinical outcomes of stereotactic brain and\/or body radiotherapy for patients with oligometastatic lesions","volume":"40","author":"Inoue","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-6-80","article-title":"Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer","volume":"6","author":"Cheruvu","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2012.09.011","article-title":"Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage","volume":"78","author":"Collaud","year":"2012","journal-title":"Lung Cancer Amst Neth"},{"key":"10.1016\/j.jtho.2019.05.037_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jtcvs.2012.05.051","article-title":"Surgery for oligometastatic\u00a0non-small cell lung cancer: long-term results from a single center experience","volume":"144","author":"Congedo","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc\u00a0Surg"},{"key":"10.1016\/j.jtho.2019.05.037_bib26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","article-title":"Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450)","volume":"7","author":"De Ruysscher","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2019.05.037_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-5002(02)00183-6","article-title":"A\u00a0phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis","volume":"38","author":"Downey","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2019.05.037_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2013.07.023","article-title":"Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors","volume":"82","author":"Griffioen","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2019.05.037_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12885-016-2379-x","article-title":"Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer","volume":"16","author":"Fleckenstein","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtho.2019.05.037_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European Organisation for Research and Treatment of Cancer imaging group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2019.05.037_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21037\/atm.2018.01.25","article-title":"The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer","volume":"6","author":"Volpi","year":"2018","journal-title":"Ann Transl Med"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086419304587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086419304587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:40:44Z","timestamp":1761561644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086419304587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1556086419304587"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2019.05.037","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining Synchronous Oligometastatic Non\u2013Small Cell Lung Cancer: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2019.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}